All Curated Mutation Sites in HIV

The Virus Mutation(VM) module provides researchers the annotations of reported pathogenic mutations in HIV related to human diseases. The curated VM information includes mutation site, mutation level, virus gene/protein/region, virus-associated disease, genotype/subtype, literature evidence, etc.

Browse Data by Virus Gene/Protein/Region, Disease OR Description

*Please select one option you are interested in, the page will be automatically redirected.

Virus Gene/Protein

Disease

Description

For highly variable viruses (e.g., HBV, HIV, SARS-CoV-2), ViMIC defaults to displaying mutations in a specific region. Click the green button to search for other regions, or click "Show All" to view all mutations (loading speed may be affected by network conditions).

Keyword: HIV Infections-30650082

ID	PMID	Mutation	Gene/Protein/Region	Encoding Gene/Protein	Disease	Description	Detail
1	30650082	A98G	RT	gag-pol	HIV Infections	D G S C L	View
2	30650082	D67N	RT	gag-pol	HIV Infections	D G S C L	View
3	30650082	E138A	RT	gag-pol	HIV Infections	D G S C L	View
4	30650082	E138G	RT	gag-pol	HIV Infections	D G S C L	View
5	30650082	E138K	RT	gag-pol	HIV Infections	D G S C L	View
6	30650082	E138Q	RT	gag-pol	HIV Infections	D G S C L	View
7	30650082	E138R	RT	gag-pol	HIV Infections	D G S C L	View
8	30650082	F77L	RT	gag-pol	HIV Infections	D G S C L	View
9	30650082	I54L	PR	gag-pol	HIV Infections	D G S C L	View
10	30650082	I54V	PR	gag-pol	HIV Infections	D G S C L	View
11	30650082	K103N	RT	gag-pol	HIV Infections	D G S C L	View
12	30650082	K20T	PR	gag-pol	HIV Infections	D G S C L	View
13	30650082	K219E	RT	gag-pol	HIV Infections	D G S C L	View
14	30650082	K219Q	RT	gag-pol	HIV Infections	D G S C L	View
15	30650082	K219R	RT	gag-pol	HIV Infections	D G S C L	View
16	30650082	K43T	PR	gag-pol	HIV Infections	D G S C L	View
17	30650082	L210W	RT	gag-pol	HIV Infections	D G S C L	View
18	30650082	L23I	PR	gag-pol	HIV Infections	D G S C L	View
19	30650082	L74I	RT	gag-pol	HIV Infections	D G S C L	View
20	30650082	L90M	PR	gag-pol	HIV Infections	D G S C L	View
21	30650082	M184V	RT	gag-pol	HIV Infections	D G S C L	View
22	30650082	M41L	RT	gag-pol	HIV Infections	D G S C L	View
23	30650082	M46I	PR	gag-pol	HIV Infections	D G S C L	View
24	30650082	M46L	PR	gag-pol	HIV Infections	D G S C L	View
25	30650082	M46V	PR	gag-pol	HIV Infections	D G S C L	View
26	30650082	T215A	RT	gag-pol	HIV Infections	D G S C L	View
27	30650082	T215C	RT	gag-pol	HIV Infections	D G S C L	View
28	30650082	T215D	RT	gag-pol	HIV Infections	D G S C L	View
29	30650082	T215E	RT	gag-pol	HIV Infections	D G S C L	View
30	30650082	T215F	RT	gag-pol	HIV Infections	D G S C L	View
31	30650082	T215N	RT	gag-pol	HIV Infections	D G S C L	View
32	30650082	T215S	RT	gag-pol	HIV Infections	D G S C L	View
33	30650082	T215Y	RT	gag-pol	HIV Infections	D G S C L	View
34	30650082	Y188L	RT	gag-pol	HIV Infections	D G S C L	View

Contents
Description

The table shows all curated mutation sites of HIV in each literature

Table Description Column Note

D
The study mentioned a certain treatment method, such as drug resistance caused by mutations.

G
The study mentioned the virus genotype/subtype information.

R
The study mentioned the reference sequence used for comparison, or the original strain of the virus used for site-directed mutagenesis.

S
The study provided sequence information or accession numbers.

L
The study provided the geographic region/country of data origin.

C
The study provided clinical baseline information.

I
The study involved information related to immune.

T
The study involved host target genes.